HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ku, H. T. Articles by Bromberg, J. S. Search for Related Content PubMed PubMed Citation Articles by Ku, H. T. Articles by Bromberg, J. S.

Committing Embryonic Stem Cells to Early Endocrine Pancreas In Vitro

Department of Gene and Cell Medicine and the Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, New York, USA

Key Words. Embryonic stem cells • Insulin I • Endocrine pancreas • In vitro differentiation

Correspondence: H. Teresa Ku, Ph.D., Box 1496, Mount Sinai School of Medicine, New York, New York 10029-6574, USA. Telephone: 212-659-8244; Fax: 212-849-2437; e-mail: hsun.ku{at}mssm.edu or Jonathan Bromberg, M.D., Ph.D., at jon.bromberg{at}mssm.edu

A panel of genetic markers was used to assess the in vitro commitment of murine embryonic stem (ES) cells toward the endoderm-derived pancreas and to distinguish insulin-expressing cells of this lineage from other lineages such as neuron, liver, and yolk sac. There are two nonallelic insulin genes in mice. Neuronal cells express only insulin II, whereas the pancreas expresses both insulin I and II. Yolk sac and fetal liver express predominately insulin II, small amounts of insulin I, and no glucagon. We found that ES-derived embryoid bodies cultured in the presence of stage-specific concentrations of monothio-glycerol and 15% fetal calf serum, followed by serum-free conditions, give rise to a population that expresses insulin I, insulin II, pdx-1 (a pancreas marker), and Sox17 (an endoderm marker). Immunohistochemical staining shows intracellular insulin particles, and its de novo production was confirmed by staining for C-peptide. Most, but not all, of the insulin⁺ or C-peptide⁺ cells coexpress glucagon, demonstrating a differentiation pathway to pancreas rather than yolk sac or fetal liver. Addition of ß-cell specification and differentiation factors activin ß B, nicotinamide, and exendin-4 to later-stage culture increased insulin-positive cells to 2.73% of the total population, compared with the control culture, which gave rise to less than 1% insulin-staining cells. These findings suggest that stepwise culture manipulations can direct ES cells to become early endocrine pancreas.

This article has been cited by other articles:

				Z. Liu and J. F. Habener Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation J. Biol. Chem., March 28, 2008; 283(13): 8723 - 8735. [Abstract] [Full Text] [PDF]

				D. Thomas, S. Friedman, and R.-Y. Lin Thyroid stem cells: lessons from normal development and thyroid cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 51 - 58. [Abstract] [Full Text] [PDF]

				J. Jiang, M. Au, K. Lu, A. Eshpeter, G. Korbutt, G. Fisk, and A. S. Majumdar Generation of Insulin-Producing Islet-Like Clusters from Human Embryonic Stem Cells Stem Cells, August 1, 2007; 25(8): 1940 - 1953. [Abstract] [Full Text] [PDF]

				A. M Ackermann and M. Gannon Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206. [Abstract] [Full Text] [PDF]

				S. Yao, S. Chen, J. Clark, E. Hao, G. M. Beattie, A. Hayek, and S. Ding Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions PNAS, May 2, 2006; 103(18): 6907 - 6912. [Abstract] [Full Text] [PDF]

				Y. Nishimura, T. S. Hamazaki, S. Komazaki, S. Kamimura, H. Okochi, and M. Asashima Ciliated Cells Differentiated from Mouse Embryonic Stem Cells Stem Cells, May 1, 2006; 24(5): 1381 - 1388. [Abstract] [Full Text] [PDF]

				S. P. Raikwar, T. Mueller, and N. Zavazava Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells Physiology, February 1, 2006; 21(1): 19 - 28. [Abstract] [Full Text] [PDF]

				G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes & Dev., May 15, 2005; 19(10): 1129 - 1155. [Abstract] [Full Text] [PDF]